APP Pharmaceuticals receives FDA approval to market Ganciclovir for Injection, USP APP Pharmaceuticals, Inc., a owned subsidiary of Fresenius Kabi Pharmaceuticals Holding wholly, Inc., announced today that it provides received approval from the U Can I get amoxicillin online? .S. Food and Drug Administration to advertise Ganciclovir for Injection, USP. APP’s Ganciclovir for Injection is normally AP-rated, latex-free and bar-coded. According to IMS Wellness, sales of the product for 2009 in the usa were approximately $13.5 million. Ganciclovir for Injection is an antiviral drug, which is used in the treating Cytomegalovirus retinitis in immunocompromised patients, including individuals with acquired immunodeficiency syndrome , aswell as for the prevention of CMV disease in transplant recipients at risk for CMV disease.
Food and Drug Administration to market Aztreonam for Injection, USP in two dosage strengths. APP’s Aztreonam is AP-rated, bar-coded and latex-free. Regarding to IMS data, 2009 sales of the branded product in the United States were approximately $86 million. The authorization of Aztreonam additional expands APP’s leading anti-infective product line. ‘The acceptance of APP’s Aztreonam marks the first generic entrant into the market and clinicians with an alternative to the branded medication,’ said John Ducker, president and ceo of APP Pharmaceuticals. ‘APP’s entry into the market also provides hospitals with yet another source of supply because of this anti-infective medicine, which is still shown on the FDA and the American Society of Health-System Pharmacists drug shortage lists because the summer of 2009.’..